Evidence map›Paper›PMID 33947777›Full record

ArticleNeurology2021

Clinical Reasoning: A 59-Year-Old Woman Presenting With Diplopia, Dysarthria, Right-Sided Weakness, and Encephalopathy.

Giovanna S Manzano, Matthew Torre, Marlise R Luskin, Henrikas Vaitkevicius

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giovanna S ManzanoFrom the Departments of Neurology (G.S.M., H.V.) and Pathology (M.T.), Brigham and Women's Hospital; and Division of Leukemia (M.R.L.), Dana-Farber Cancer Institute, Boston, MA. gmanzano@partners.org.ORCID 0000-0002-9991-9222
Matthew TorreFrom the Departments of Neurology (G.S.M., H.V.) and Pathology (M.T.), Brigham and Women's Hospital; and Division of Leukemia (M.R.L.), Dana-Farber Cancer Institute, Boston, MA.
Marlise R LuskinFrom the Departments of Neurology (G.S.M., H.V.) and Pathology (M.T.), Brigham and Women's Hospital; and Division of Leukemia (M.R.L.), Dana-Farber Cancer Institute, Boston, MA.
Henrikas VaitkeviciusFrom the Departments of Neurology (G.S.M., H.V.) and Pathology (M.T.), Brigham and Women's Hospital; and Division of Leukemia (M.R.L.), Dana-Farber Cancer Institute, Boston, MA.

Funding

VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
NHLBI NIH HHS T32 HL007627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical ReasoningAntimetabolites, AntineoplasticConfusionDiplopiaDysarthriaFemaleHumansLeukemia, Myeloid, AcuteMethotrexateMiddle AgedMuscle WeaknessNeurotoxicity SyndromesSleepinessAntimetabolites, AntineoplasticMethotrexate

Identifiers

PMID33947777
PMCPMC9245924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.